Altered expression of SIRPγ on the T-cells of relapsing remitting multiple sclerosis and type 1 diabetes patients could potentiate effector responses from T-cells-Reference-Cited by-同舟云学术

Altered expression of SIRPγ on the T-cells of relapsing remitting multiple sclerosis and type 1 diabetes patients could potentiate effector responses from T-cells

Published:2020-08-27 Issue:8 Volume:15 Page:e0238070
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Sinha Sushmita^ORCID,Renavikar Pranav S.,Crawford Michael P.,Steward-Tharp Scott M.,Brate Ashley,Tsalikian Eva,Tansey Michael,Shivapour Ezzatollah T.,Cho Tracey,Kamholz John,Karandikar Nitin J.

Funder

Foundation for the National Institutes of Health

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference34 articles.

1. The SIRP family of receptors and immune regulation;A.N. Barclay;Nature reviews. Immunology,2006

2. Adhesion of human T cells to antigen-presenting cells through SIRPbeta2-CD47 interaction costimulates T-cell proliferation;L. Piccio;Blood,2005

3. Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes;Type 1 Diabetes Genetics;Nature genetics,2009

4. Association of 32 type 1 diabetes risk loci in Pakistani patients;A.K. Kiani;Diabetes research and clinical practice,2015

5. Association between type 1 diabetes and GWAS SNPs in the southeast US Caucasian population;M.V. Reddy;Genes and immunity,2011

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genomic determinants of antibody response to a typhoid vaccine in Indian recipients;Journal of Genetics;2024-02-28

2. Potential disease biomarkers for diabetic retinopathy identified through Mendelian randomization analysis;Frontiers in Endocrinology;2024-01-11

3. Integrated bioinformatics analysis reveals novel key biomarkers in diabetic nephropathy;2022-09-19

4. Integrated bioinformatics analysis reveals novel key biomarkers in diabetic nephropathy;SAGE Open Medicine;2022-01

5. Clinically Relevant Circulating Protein Biomarkers for Type 1 Diabetes: Evidence From a Two-Sample Mendelian Randomization Study;Diabetes Care;2021-11-10